Cash Balance: EUR 30 million at the end of June.Fundraising: EUR 35.5 million raised in the first half.Operating Loss: Slightly lower than the previous year.Sh
Aug 28, 2024 / 12:00PM GMTJuho Jalkanen - Faron Pharmaceuticals Oy - Chief Operating Officer Welcome, everybody, to the H1 results webcast of Faron Pharmaceutic
The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News:
----------
Faron Pharmaceuticals Oy - Finland-based...
Mar 13, 2024 / 12:00PM GMTMarkku Jalkanen - Faron Pharmaceuticals Oy - CEO & Founder Good afternoon to the Europeans, and good morning for the US people. Thank
Jan 11, 2024 / 08:00PM GMTJosh Bowers JPMorgan-Analyst Good afternoon, everyone. Welcome to the final day of the JPMorgan conference. I'm Josh Bowers from the L
Oct 11, 2023 / 12:00PM GMTMarkku Jalkanen - Faron Pharmaceuticals Oy - CEO and Founder Good afternoon to all in Europe, and good morning for those on the other
Aug 10, 2023 / 04:30PM GMTJohn Newman - Canaccord Genuity Group Inc. - Analyst Good afternoon, everyone, and thank you for joining us at the 43rd Annual Canacco
Aug 29, 2023 / 12:00PM GMTMarkku Jalkanen - Faron Pharmaceuticals Oy - CEO and Founder Hello, everyone. Thank you for joining us for this webcast on H1 '23 resu
Jul 19, 2023 / 12:30PM GMTOperator Greetings and welcome to the Faron Pharmaceuticals' BEXMAB study update. (Operator Instructions) As a reminder, this conferen
16 December 2022 HARGREAVE HALE AIM VCT PLC Full Year Results and Notice of AGM Hargreave Hale AIM VCT plc announces its results for the year ended 30 September 2022. The... | December 19, 2022